Amcor (AMCCD) Financials
Newest figures come from the 10-Q for Q3 FY2026, filed May 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMCCD SEC filings page.
Amcor (AMCCD) reported $22.2B in revenue over the twelve months to Mar 31, 2026, up 64.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
Amcor’s business expanded through a balance-sheet-heavy expansion, while reinvestment and financing costs weakened cash conversion.
FY2025 operating cash flow was272.0% of net income, so reported profit still translated into cash before reinvestment. Yet free cash flow fell12.1% as capital expenditures rose19.8% , showing that capital spending absorbed more of the cash conversion even while earnings remained cash-generative.
Revenue rose
Debt-to-equity fell to 1.2x from 1.7x even as borrowing increased, so the improved leverage ratio largely reflects a larger equity base rather than less debt. Meanwhile, accounts receivable rose
Financial Health Signals
We do not publish a peer-relative financial health score for Amcor, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Amcor passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Amcor generates $2.72 in operating cash flow ($1.4B OCF vs $511.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Amcor earns $2.55 in operating income for every $1 of interest expense ($1.0B vs $396.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Amcor generated $5.9B in revenue in Q3 2026. This represents an increase of 77.4% from the same quarter a year earlier. Against the prior quarter it is up 8.5%.
Amcor's EBITDA was $807.0M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 81.8% from the same quarter a year earlier. Against the prior quarter it is up 14.5%.
Amcor reported $278.0M in net income in Q3 2026. This represents an increase of 41.8% from the same quarter a year earlier. Against the prior quarter it is up 57.1%.
Amcor earned $0.60 per diluted share (EPS) in Q3 2026. Against the prior quarter it is up 57.9%.
Cash & Balance Sheet
Amcor recorded an outflow of $42.0M in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 114.9%.
Amcor held $1.6B in cash against $15.2B in long-term debt as of Q3 2026.
Amcor paid $0.65 per share in dividends in Q3 2026. It is unchanged from the prior quarter.
Margins & Returns
Amcor's gross margin was 20.1% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.
Amcor's operating margin was 7.8% in Q3 2026, reflecting core business profitability. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.
Amcor's net profit margin was 4.7% in Q3 2026, showing the share of revenue converted to profit. This is down 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.
Amcor's quarterly ROE was 2.4% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.
Capital Allocation
Amcor invested $44.0M in research and development in Q3 2026. This represents an increase of 63.0% from the same quarter a year earlier. Against the prior quarter it is up 15.8%.
Amcor invested $228.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 94.9% from the same quarter a year earlier. Against the prior quarter it is up 3.2%.
Not reported for Q3 2026.
AMCCD Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'26Filing | Q4'25Filing | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B+77.4% | $5.4B+68.1% | $5.7B+71.3% | $5.1B+43.8% | $3.3B-2.3% | $3.2B-0.3% | $3.4B-2.6% | $3.5B |
| Cost of Revenue | $4.7B+76.3% | $4.4B+68.6% | $4.6B+71.5% | N/A | $2.7B-1.5% | $2.6B-0.6% | $2.7B-3.7% | N/A |
| Gross Profit | $1.2B+82.0% | $1.0B+66.0% | $1.1B+70.6% | $895.0M+18.7% | $654.0M-5.5% | $626.0M+0.8% | $659.0M+2.2% | $754.0M |
| R&D Expenses | $44.0M+63.0% | $38.0M+40.7% | $46.0M+64.3% | N/A | $27.0M+8.0% | $27.0M-3.6% | $28.0M+3.7% | N/A |
| SG&A Expenses | $488.0M+83.5% | $440.0M+72.5% | $435.0M+57.6% | N/A | $266.0M-19.4% | $255.0M-14.7% | $276.0M-8.6% | N/A |
| Operating Income | $461.0M+47.3% | $331.0M+11.4% | $461.0M+47.8% | N/A | $313.0M+2.0% | $297.0M+22.7% | $312.0M+15.6% | N/A |
| EBITDA | $807.0M+81.8% | $705.0M+65.1% | $825.0M+82.1% | N/A | $444.0M | $427.0M | $453.0M+8.1% | N/A |
| Interest Expense | $170.0M+100.0% | $169.0M+108.6% | $168.0M+95.3% | N/A | $85.0M-4.5% | $81.0M-9.0% | $86.0M+1.2% | N/A |
| Income Tax | $32.0M-20.0% | $3.0M-94.8% | $49.0M+14.0% | N/A | $40.0M0.0% | $58.0M+107.1% | $43.0M+10.3% | N/A |
| Net Income | $278.0M+41.8% | $177.0M+8.6% | $262.0M+37.2% | -$39.0M-115.2% | $196.0M+4.8% | $163.0M+21.6% | $191.0M+25.7% | $257.0M |
| EPS (Basic) | $0.60 | $0.38 | $0.11 | -$0.02-110.7% | $0.68 | $0.57 | $0.13+25.7% | $0.18 |
| EPS (Diluted) | $0.60 | $0.38 | $0.11 | -$0.02-110.7% | $0.68 | $0.56 | $0.13+25.7% | $0.18 |
| Diluted Shares (Avg) | 464M | 464M | 2.31B | N/A | 289M | 289M | 1.44B+0.3% | N/A |
AMCCD Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'26Filing | Q4'25Filing | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $37.6B+108.3% | $37.0B+129.2% | $37.1B+119.7% | $37.1B+124.3% | $18.0B+8.3% | $16.2B-3.4% | $16.9B+1.9% | $16.5B-2.8% |
| Current Assets | $9.8B+46.6% | $8.6B+74.5% | $8.5B+62.8% | $8.4B+69.9% | $6.7B+33.3% | $4.9B-1.1% | $5.2B+15.6% | $5.0B-6.5% |
| Cash & Equivalents | $1.6B-22.4% | $1.1B+137.5% | $825.0M+91.0% | $827.0M+40.6% | $2.0B+347.5% | $445.0M+3.5% | $432.0M-56.3% | $588.0M-14.7% |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | $1.4B+4.9% | N/A |
| Accounts Receivable | $3.5B+78.4% | $3.2B+78.1% | $3.4B+73.8% | $3.4B+85.6% | $2.0B+1.8% | $1.8B-2.5% | $2.0B+57.0% | $1.8B-1.5% |
| Goodwill | $12.0B+125.4% | $11.9B+125.5% | $11.4B+112.1% | $11.3B+111.0% | $5.3B-1.0% | $5.3B-2.1% | $5.4B+28.6% | $5.3B-0.4% |
| Total Liabilities | $25.9B+82.8% | $25.4B+105.3% | $25.4B+96.8% | $25.3B+101.5% | $14.2B+12.1% | $12.4B-2.6% | $12.9B-3.4% | $12.6B-2.6% |
| Current Liabilities | $6.8B+72.9% | $6.6B+68.8% | $8.2B+101.2% | $7.0B+64.0% | $3.9B+0.7% | $3.9B-1.8% | $4.1B+49.9% | $4.3B-4.8% |
| Non-Current Liabilities | $19.1B+86.5% | $18.8B+122.0% | $17.2B+94.7% | $18.3B+120.7% | $10.2B+17.2% | $8.5B-2.9% | $8.8B+1.5% | $8.3B-1.5% |
| Long-Term Debt | $15.2B+76.0% | $14.6B+113.8% | $12.8B+78.7% | $13.8B+109.6% | $8.6B+22.4% | $6.8B-2.5% | $7.2B-20.0% | $6.6B-0.8% |
| Total Equity | $11.7B+202.5% | $11.6B+207.5% | $11.7B+199.0% | $11.7B+202.2% | $3.9B-2.4% | $3.8B-4.5% | $3.9B+21.9% | $3.9B-3.6% |
| Retained Earnings | $371.0M-57.9% | $393.0M-54.8% | $516.0M-42.0% | $548.0M-37.7% | $881.0M+9.9% | $869.0M+9.3% | $890.0M-61.6% | $879.0M+1.6% |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
AMCCD Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'26Filing | Q4'25Filing | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $186.0M+59.0% | $503.0M+17.5% | -$133.0Mn/m | $1.1B | $117.0M-22.0% | $428.0M+17.9% | -$269.0Mn/m | N/A |
| Depreciation & Amortization | $346.0M+164.1% | $374.0M+187.7% | $364.0M+158.2% | N/A | $131.0M | $130.0M | $141.0M-5.4% | N/A |
| Stock-Based Compensation | N/A | N/A | $10.0M+100.0% | N/A | N/A | N/A | $5.0Mn/m | N/A |
| Capital Expenditures | $228.0M+94.9% | $221.0M+125.5% | $238.0M+64.1% | $220.0M | $117.0M+3.5% | $98.0M-19.0% | $145.0M+16.9% | N/A |
| Free Cash Flow | -$42.0Mn/m | $282.0M-14.5% | -$371.0Mn/m | $894.0M | $0-100.0% | $330.0M+36.4% | -$414.0Mn/m | N/A |
| Investing Cash Flow | -$155.0Mn/m | -$215.0M-1123.8% | -$226.0Mn/m | -$1.9B | -$115.0Mn/m | $21.0Mn/m | -$155.0Mn/m | N/A |
| Financing Cash Flow | $528.0M-66.8% | -$67.0Mn/m | $358.0M+51.1% | -$538.0M | $1.6Bn/m | -$380.0Mn/m | $237.0M+68.1% | N/A |
| Dividends Paid | $300.0M+63.0% | $300.0M+61.3% | $294.0M+63.3% | $295.0M | $184.0M+1.7% | $186.0M+0.5% | $180.0M+2.3% | N/A |
| Share Buybacks | N/A | N/A | N/A | $0 | $0n/m | $0n/m | $0-100.0% | N/A |
AMCCD Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'26Filing | Q4'25Filing | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 20.1%+0.5pp | 19.1%-0.3pp | 19.6%-0.1pp | 17.6%-3.7pp | 19.6%-0.7pp | 19.3%+0.2pp | 19.7%+0.9pp | 21.3% |
| Operating Margin | 7.8%-1.6pp | 6.1%-3.1pp | 8.0%-1.3pp | N/A | 9.4%+0.4pp | 9.2%+1.7pp | 9.3%+1.5pp | N/A |
| Net Margin | 4.7%-1.2pp | 3.3%-1.8pp | 4.6%-1.1pp | -0.8%-8.0pp | 5.9%+0.4pp | 5.0%+0.9pp | 5.7%+1.3pp | 7.3% |
| Return on Equity | 2.4%-2.7pp | 1.5%-2.8pp | 2.2%-2.6pp | -0.3%-6.9pp | 5.1%+0.4pp | 4.3%+0.9pp | 4.9%+0.1pp | 6.6% |
| Return on Assets | 0.7%-0.3pp | 0.5%-0.5pp | 0.7%-0.4pp | -0.1%-1.7pp | 1.1%0.0pp | 1.0%+0.2pp | 1.1%+0.2pp | 1.6% |
| Current Ratio | 1.44-0.3x | 1.300.0x | 1.04-0.2x | 1.210.0x | 1.70+0.4x | 1.260.0x | 1.29-0.4x | 1.170.0x |
| Debt-to-Equity | 1.30-0.9x | 1.26-0.6x | 1.09-0.7x | 1.18-0.5x | 2.24+0.5x | 1.810.0x | 1.83-1.0x | 1.700.0x |
| Liabilities-to-Equity | 2.22-1.5x | 2.18-1.1x | 2.17-1.1x | 2.16-1.1x | 3.68+0.5x | 3.27+0.1x | 3.30-0.9x | 3.240.0x |
| Asset Turnover | 0.160.0x | 0.15-0.1x | 0.150.0x | 0.14-0.1x | 0.180.0x | 0.200.0x | 0.200.0x | 0.21 |
| FCF Margin | -0.7%-0.7pp | 5.2%-5.0pp | -6.5%+5.9pp | 17.6% | 0.0%-1.1pp | 10.2%+2.7pp | -12.3%-4.8pp | N/A |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Amcor AMCCD | FY2025 | $15.0B | $511.0M | 3.4% | N/A | — |
| Amcor plc CDI AMCCF | FY2026 | $23.5B | $1.1B | 4.7% | $22.0B | — |
Where Amcor Ranks
Frequently Asked Questions
Amcor (AMCCD) reported $15.0B in total revenue for fiscal year 2025. This represents a 10.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Amcor (AMCCD) revenue grew by 10.0% year-over-year, from $13.6B to $15.0B in fiscal year 2025.
Yes, Amcor (AMCCD) reported a net income of $678.0M over the trailing 12 months to March 31, 2026. In fiscal year 2025 it reported a net income of $511.0M, with a net profit margin of 3.4%.
Amcor (AMCCD) had EBITDA of $1.7B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Amcor (AMCCD) had $827.0M in cash and equivalents against $13.8B in long-term debt.
Amcor (AMCCD) had a gross margin of 18.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Amcor (AMCCD) had an operating margin of 6.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Amcor (AMCCD) had a net profit margin of 3.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Yes, Amcor (AMCCD) paid $0.51 per share in dividends during fiscal year 2025.
Amcor (AMCCD) has a return on equity of 4.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Amcor (AMCCD) generated $810.0M in free cash flow during fiscal year 2025. This represents a -12.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Amcor (AMCCD) generated $1.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Amcor (AMCCD) had $37.1B in total assets as of fiscal year 2025, including both current and long-term assets.
Amcor (AMCCD) invested $580.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Amcor (AMCCD) invested $120.0M in research and development during fiscal year 2025.
Amcor (AMCCD) had a current ratio of 1.21 as of fiscal year 2025, which is considered adequate.
Amcor (AMCCD) had a debt-to-equity ratio of 1.18 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Amcor (AMCCD) had a liabilities-to-equity ratio of 2.16 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Amcor (AMCCD) had a return on assets of 1.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Amcor (AMCCD) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Amcor (AMCCD) has an earnings quality ratio of 2.72x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Amcor (AMCCD) has an interest coverage ratio of 2.55x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.